A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

"SHAT Joan Pavel OOD [Hemorrhagic Diathesis and Anemia]", Sofia

Hospital of the University of Pennsylvania, Philadelphia

Universitätsklinikum Hamburg-Eppendorf, Abt für Pädiatr. Hämatologie, Hamburg

H.U. La Paz [Coagulopatias Congénitas], Madrid

Zentralkrankenhaus Prof. Hess-Kinderklinik, Bremen

Centre Hospitalier Universitaire de Brest/CHU Morvan, Brest

Osp. S.Bortolo ULSS N.6 [Terapie Cell. ed Ematologia], Vicenza

A.O.U. di Parma [Centro di Rif. Reg. per la cura dell'Emofil, Parma

Indiana Hemophilia and Thrombosis Center, Inc., Indianapolis

BloodCenter of Wisconsin, Milwaukee

Rush University Medical Center, Chicago

Hôpital Necker-CRTH, Paris

C.R.T.H. Hôp. Bicêtre-Hémophilie, Le Kremlin-Bicêtre

"FGU Kirov Research Institute of Haemotology and Blood Trans", Kirov

AKH Wien [Hämatologie, Hämostaseol, Vienna

Instit. für Experimentelle - Hämato & Transfusionsmedizin, Bonn

Unikinderklinik Frankfurt/Main [Kinderheilkunde], Frankfurt

Werlhof-Inst. Hannover, Hanover

Chaim Sheba Medical Center, Tel Aviv

IRCCS Ospedale Maggiore[Centro emofilia e Trombosi], Milan

University of Occupational and Environmental Health, Kitakyushu

The Hospital of Hyogo College of Medicine, Nishinomiya

Tokyo Medical University Hospital, Tokyo

C.H.U. A Coruña [Hematología], A Coruña

H.U.Vall d'Hebrón [Hemofillia], Barcelona

CHU de Lyon - Hôpital Edouard Herriot [Hemophilie], Lyon

Nara Medical University Hospital [PEDIATRICS], Kashihara

Nagoya University Hospital, Nagoya

Ogikubo Hospital, Tokyo

St. Marianna University, School of Medicine, Yokohama Seibu, Yokohama